Skip to content

FEmoral BOne fracture study

Protein synthesis rates of muscle and bone tissue in femoral bone fracture patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON20798
Enrollment
10
Registered
2020-11-04
Start date
2020-12-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip fracture

Interventions

None

Sponsors

Maastricht University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Written informed consent; 2) Recent (<24 h before admission to the hospital) femoral bone fracture requiring hip replacement surgery; 3) Admitted to MUMC+ to receive a femoral head-neck prosthesis or total hip replacement.

Exclusion criteria

Exclusion criteria: 1) Physical restlessness due to delirium; 2) Rheumatoid arthritis; 3) Chemotherapy or radiotherapy; 4) (Multiple) Myeloma or other primary cancer tumor with possible bone metastasis;)5) Collagen disorders, e.g. Marfan and Ehler-Danlos; 6) Any other medical condition that may interfere with the safety of the subjects or the outcome parameters, in the investigators judgement; 7) Investigator’s uncertainty about the willingness or ability of the subject to comply with the protocol instructions; 8) Participation in any other studies involving investigational or marketed products concomitantly to entry into the study.

Design outcomes

Primary

MeasureTime frame
Bone protein synthesis rates in the femoral shaft and femoral head tissue, expressed in FSR (%/h)

Secondary

MeasureTime frame
The secondary outcome parameters are tissue-specific protein synthesis rates in femoral bone, femoral head cartilage, hip synovium, and m. gluteus maximus, expressed in FSR (%/h).

Contacts

Public ContactFloris Hendriks

Maastricht University Medical Centre+ / NUTRIM School of Nutrition and Translational Research in Metabolism / Department of Human Biology

f.hendriks@maastrichtuniversity.nl0655522347

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)